Young Adult Stroke Rates Jump Over 30 Years

Young Adult Stroke Rates Jump Over 30 Years

National stroke rates among adults ages 20 to 54 nearly doubled over a three-decade period, climbing from 33.9 cases per 100,000 person-years in 1993-1994 to 62.2 cases per 100,000 person-years in 2020, according to data from the Greater Cincinnati/Northern Kentucky Stroke Study published in Neurology. Researchers report that ischemic strokes caused by blocked blood flow … Read more

Tirzepatide Cuts Fat Mass by 35% While Preserving Muscle

Weight loss in muscular woman

Adults taking tirzepatide lose an average of 15 kilograms over six months while experiencing a 35% reduction in fat mass and preserving skeletal muscle. A study published in the Journal of Diabetes and Its Complications tracked 122 overweight and obese patients in Palermo, Italy, to measure real-world changes in body composition and metabolic health. Patient … Read more

Study Finds GLP-1s Benefit Children With Type 2 Diabetes

Study Finds GLP-1s Benefit Children With Type 2 Diabetes

A real-world study presented at the European Association for the Study of Diabetes on Sept. 30, 2026, found that GLP-1 receptor agonists—such as Wegovy and Zepbound—helped young patients with type 2 diabetes reduce their weight, lower blood pressure, and improve blood sugar control. Clinical Benefits for Young Patients The study tracked nearly 1,900 participants aged … Read more

Organ Mutation Rates Explain Cancer Risk Differences

Organ Mutation Rates Explain Cancer Risk Differences

A new study published in Cancer Research reveals that healthy individuals exhibit surprisingly large differences in their organ mutation burdens, with some people carrying up to eight times more mutations than others—levels comparable to those found in cancer patients. Conducted by scientists at City of Hope and TGen, the research analyzed whole-genome and whole-exome sequencing … Read more

Reversing Type 2 Diabetes: How Mauritius Did It

Reversing Type 2 Diabetes: How Mauritius Did It

Mauritius has become the first country in the world to prove it is reversing its type 2 diabetes epidemic, according to new research published in The Lancet Diabetes & Endocrinology. The findings, set to be presented at the Annual Meeting of the European Association for the Study of Diabetes in Milan, Italy, show a sustained … Read more

Why Women Report More GLP-1 Side Effects: Real-World Data

Global obesity rates for women are projected to reach 60·3% by 2050, according to a recent analysis by the Global Burden of Disease group cited in a new series of papers presented at the Annual Meeting of The European Association for the Study of Diabetes in Milan, Italy. Published in The Lancet Obstetrics, Gynaecology & … Read more

Indigenous foods like tarwi and quinoa offer chronic disease benefits

Traditional Indigenous food systems in North America and the Andes offer a nutritional framework for addressing chronic disease, though scientific characterization of these crops remains limited. Research published in Current Developments in Nutrition indicates that staples like the Three Sisters crops, quinoa, and tarwi provide essential bioactive compounds, yet clinical evidence for many of these … Read more

How GLP-1 Drugs Impact Chronic Pain: Gut-Brain & Immune Links

Odonkor, M.R. Dodurgali, F.R. Cox, I.J. Klimov, and A. Abd-Elsayed in the journal Nutrients, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may alleviate chronic pain by interacting with the gut microbiome and the gut-brain axis. The study examines how microbial metabolites, spinal microglia, and dietary signaling intersect with pain sensitization pathways. Gut Microbiota and GLP-1 Signaling … Read more

BPA-Free Chemical Linked to Diabetes Risk

Higher plasma concentrations of bisphenol S (BPS)—a common substitute for bisphenol A (BPA)—are positively associated with elevated glycated hemoglobin (HbA1c) levels in adults with type 2 diabetes, according to a study published in the journal Acta Diabetologica. Researchers analyzing data from 307 participants at the University of Pittsburgh Medical Center (UPMC) found that while BPS … Read more

City of Hope Develops Modular Plug-and-Play CAR T Therapy for Tumors

Organ Mutation Rates Explain Cancer Risk Differences

City of Hope investigators have formulated an innovative plug-and-play technique that incorporates engineered molecules into chimeric antigen receptor (CAR) T cells post-treatment, based on findings shared this month in Cancer Immunology Research, an American Association for Cancer Research journal. The preclinical study offers a flexible approach to help CAR T cells keep pace with mutating … Read more